Uric acid as a predictor for early allograft dysfunction after living donor liver transplantation: A prospective observational study

Li Min Hu, Hsin I. Tsai, Chao Wei Lee, Hui Ming Chen, Wei Chen Lee, Huang Ping Yu*

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

5 Scopus citations

Abstract

Early allograft dysfunction (EAD) is a postoperative complication that may cause graft failure and mortality after liver transplantation. The objective of this study was to examine whether the preoperative serum uric acid (SUA) level may predict EAD. We performed a prospective observational study, including 61 donor/recipient pairs who underwent living donor liver transplantation (LDLT). In the univariate and multivariate analysis, SUA ≤4.4 mg/dL was related to a five-fold (odds ratio (OR): 5.16, 95% confidence interval (CI): 1.41–18.83; OR: 5.39, 95% CI: 1.29–22.49, respectively) increased risk for EAD. A lower preoperative SUA was related to a higher incidence of and risk for EAD. Our study provides a new predictor for evaluating EAD and may exert a protective effect against EAD development.

Original languageEnglish
Article number2729
JournalJournal of Clinical Medicine
Volume10
Issue number12
DOIs
StatePublished - 06 2021

Bibliographical note

Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.

Keywords

  • Antioxidant
  • Early allograft dysfunction
  • Liver transplantation
  • Oxidative stress
  • Reperfusion injury
  • Uric acid
  • Uric acid therapy

Fingerprint

Dive into the research topics of 'Uric acid as a predictor for early allograft dysfunction after living donor liver transplantation: A prospective observational study'. Together they form a unique fingerprint.

Cite this